Skip to main content
PRIMR24 Main banner
Icon Legend
Presentation Icons
Human Subject Research - HSR
Human Subject Research - HSR
ACU/IACUC
ACU/IACUC
Institutional Leadership
Institutional Leadership
Crossover
Crossover
Live Streamed Session
Live Streamed Session
Live Session Recorded
Live Session Recorded
Pre-Reg Required
Pre-Reg Required
Additional Fee
Additional Fee
On-Demand Session
On-Demand Session
CIP Accredited
CIP Accredited
CPIA Accredited
CPIA Accredited
Workshop Series
Workshop Series
Thought Leader Series
Thought Leader Series
Deep Dive Series
Deep Dive Series
Learning Lab Series
Learning Lab Series
Networking Series
Networking Series
Vendor Insight Series
Vendor Insight Series
Pillars of PRIM&R Poster Award
Pillars of PRIM&R Poster Award
Call for Session Proposal - CSP
Call for Session Proposal - CSP
Back

Rita T. Lawlor

ARC-Net and Department of Engineering for Innovative Medicine, University of Verona, Italy, Veneto, Italy

Rita T. Lawlor is a Health Research, ICT and privacy professional with 25 years’ management experience and a proven record of leading health and research innovation and delivering results. She has held Directorships and leading positions in biobanking and research organizations and has extensive international experience. Rita Lawlor is co-founder of the ARC-Net applied cancer research centre where she is vice director of the centre and runs the cancer biobank.

Rita is originally a Computer Science graduate with a doctorate in translational biomedical sciences in Oncological Pathology. She was conferred with a fellow of Information Privacy from IAPP (International Association of Privacy Professionals). Her current research interests are in molecular diagnostic markers and therapeutic targets and the role of cancer heterogeneity and molecular characterization of samples in the application of personalized medicine.

She is chair of the Science Policy Commnity of Practice of ISBER, International Society for Biological and Environmental Repositories (www.isber.org). She is chair of the International Cancer Genome Consortium ARGO Ethics and Governance Committee (www.icgc-argo.org) and is part of the Lancet Oncology commission for cancer omics, precision oncology where she heads the sub section on ethics, governance and legal considerations. She is vice president of the Italian Foundation for Pancreas diseases (FIMP). She is a member of the steering committee of BC-NET (Biobank Cohort Network of Low Middle Income Countries) network of IARC (International Association for Research on Cancer).

Presentation(s):